Breaking News

CiToxLAB Appoints Toxicology/Ops Director

January 29, 2013

Foulon joins executive committee

Dr. Olivier Foulon has been appointed director of toxicology and operations at CiToxLAB’s (CIT) site in Evreux, France. Dr. Foulon has also been nominated as deputy managing director of CiToxLAB-France, becoming a member of the executive committee.
Dr. Foulon has more than 20 years of experience in preclinical safety in the pharmaceutical, chemical and cosmetic industries. He began his career in toxicology at Bayer Crop Science and joined CIT as senior toxicologist and later became director of the department. He also served as director of experimental toxicology at Pierre Fabre Laboratories, where he managed development programs for drugs, cosmetics and medical devices.
“I am very happy that CiToxLAB Group is capable of attracting talents such as Olivier Foulon. Olivier is a recognized toxicologist with broad experience and a successful career as customer and a service provider. He is also a strong organizer and a demanding manager. I know that some of our European customers who already know him are delighted about his return. His expertise and energy will be key leverage points in a period when CiToxLAB Group is undergoing strong development, both in Europe and in North America at our site in Montréal-Laval,” said Jean-François Le Bigot, chairman and chief executive officer of CiToxLAB.

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity